{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T10:42:30Z","timestamp":1648982550151},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.contraception.2014.08.015","type":"journal-article","created":{"date-parts":[[2014,9,6]],"date-time":"2014-09-06T16:48:49Z","timestamp":1410022129000},"page":"618-621","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Reply to letter to the editor: \u201cThe INAS-OC study\u201d"],"prefix":"10.1016","volume":"90","author":[{"given":"J\u00fcrgen","family":"Dinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2014.08.015_bb0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.contraception.2014.01.023","article-title":"Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives","volume":"89","author":"Dinger","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.08.015_bb0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.contraception.2012.09.015","article-title":"Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users","volume":"87","author":"Sidney","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.08.015_bb0015","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2014.08.015_bb0020","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/AOG.0b013e3182a5ec6b","article-title":"Cardiovascular risk associated with the use of an etonogestrel-containing vaginal ring","volume":"122","author":"Dinger","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2014.08.015_bb0025","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1136\/bmj.e2990","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10","volume":"344","author":"Lidegaard","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2014.08.015_bb0030","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1701-2163(16)31016-7","article-title":"Absolute and attributable risk of venous thromboembolism in women on combined cyproterone acetate and ethinylestradiol","volume":"25","author":"Lidegaard","year":"2003","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.contraception.2014.08.015_bb0035","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0010-7824(00)00149-9","article-title":"Oral contraceptives and cardiovascular outcomes: cause or bias?","volume":"62","author":"Spitzer","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.08.015_bb0040","first-page":"126","article-title":"Contraception and thrombophilia \u2014 a statement from the German Society for Gynecological Endocrinology and Reproductive Medicine (DGGEF e.V.) and the Professional Association of German Gynaecologists","volume":"8","author":"Rabe","year":"2011","journal-title":"J Reproduktionsmed Endokrinol"},{"key":"10.1016\/j.contraception.2014.08.015_bb0045","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1053\/ob.1998.v179.a91674","article-title":"Thrombotic diseases in young women and the influence of oral contraceptives","volume":"179","author":"Lidegaard","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2014.08.015_bb0050","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.AOG.0000279448.62221.a8","article-title":"Risk of thromboembolism in women taking ethinylestradiol\/drospirenone and other oral contraceptives","volume":"110","author":"Seeger","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2014.08.015_bb0055","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782414006507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782414006507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T01:00:19Z","timestamp":1538269219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782414006507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0010782414006507"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2014.08.015","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reply to letter to the editor: \u201cThe INAS-OC study\u201d","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2014.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}